Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/57941| Conference/Presentation Title: | Prognostic significance of gleason grade at the surgical margin following radical prostatectomy. | Authors: | Khanna Y.;Ranasinghe W.;Wei X. | Institution: | (Wei, Ranasinghe) Monash University, Clayton, Australia (Khanna, Ranasinghe) Monash Health, Clayton, Australia |
Presentation/Conference Date: | 19-Mar-2026 | Copyright year: | 2026 | Publisher: | John Wiley and Sons Inc | Conference location: | Netherlands | Publication information: | BJU International. Conference: 78th Annual Scientific Meeting of Urological Society of Australia and New Zealand, USANZ 2026. Melbourne, VIC Australia. 137(Supplement 2) (pp S178-S179), 2026. Date of Publication: 01 Feb 2026. | Journal: | BJU International | Abstract: | Introduction & Objectives: The prognostic significance of a positive surgical margin (PSM) after radical prostatectomy (RP) is well-established. However, the clinical impact of a PSM containing only low-grade Gleason 3 cancer is less certain - its virtually non-existent metastatic potential has ignited debate over whether it should be classified as 'cancer' at all. Therefore, we aim to evaluate the risk of biochemical recurrence (BCR) in patients with an isolated Gleason 3 PSM compared to those with negative surgical margins (NSM). Method(s): We retrospectively analysed a cohort of 135 patients who underwent RP between 2019 and 2022. BCR free survival was compared across margin status groups (NSM, Gleason 3, 4, or 5 at margin) using Kaplan-Meier analysis and multivariable Cox regression. Result(s): Overall, 129 patients were included. Table 1 on Kaplan-Meier analysis, Fig. 1 there was no statistically significant difference in BCR-free survival between the NSM group and the Gleason 3 at the margin group (P = 0.15). The rate of salvage or adjuvant radiotherapy is 30.8% vs 19.3% for Gleason 3 at PSM and NSM respectively. In contrast, Gleason 4 or 5 at the margin was associated with significantly worse BCR-free survival (P < 0.0001). In multivariable analysis, independent predictors of BCR were advanced pathological stages (pT3-4: HR 2.21, P = 0.03), Gleason 4 at the margin (HR 3.04, P = 0.005), and Gleason 5 at the margin (HR 4.54, P = 0.02). Conclusion(s): An isolated Gleason 3 PSM does not significantly increase BCR risk compared to NSM following RP. The grade of the cancer at the margin is a critical prognostic factor, with higher-grade disease conferring a significantly greater risk of BCR. These findings suggest that patients with an isolated Gleason 3 positive margin may be candidates for observation rather than aggressive adjuvant therapy. | Conference Name: | 78th Annual Scientific Meeting of Urological Society of Australia and New Zealand, USANZ 2026 | Conference Start Date: | 2026-02-28 | Conference End Date: | 2026-03-03 | Conference Location: | Melbourne, VIC, Australia | DOI: | https://dx.doi.org/10.1111/bju.70141 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/57941 | Type: | Conference Abstract |
| Appears in Collections: | Conference Abstracts |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
